The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Sanghee | - |
dc.contributor.author | Na, Younghyun | - |
dc.contributor.author | Joung, Sung Yup | - |
dc.contributor.author | Lee, Sun Il | - |
dc.contributor.author | Oh, Sang Cheul | - |
dc.contributor.author | Min, Byung Wook | - |
dc.date.available | 2020-11-02T07:42:07Z | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.issn | 1536-5964 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/3792 | - |
dc.description.abstract | The colorectal cancer (CRC) patients with microsatellite instability (MSI) have distinct clinicopathological characteristics consisting of factors predicting positive and negative outcomes, such as a high lymph node harvest and poor differentiation. In this study, we measured the value of MSI as a prognostic factor after controlling for these discrepant factors. A total of 603 patients who underwent curative surgery for stages I to III colorectal cancer were enrolled. The patients were divided into microsatellite instability high (MSI-H) and microsatellite stable/microsatellite instability low (MSS/MSI-L) groups. Propensity score matching was used to match clinicopathological factors between the 2 groups. MSI-H patients had a high lymph node harvest (median: 31.0 vs 23.0, P<.001), earlier-stage tumors (P<.001), advanced T stage (89.3% vs 74.0%, P=.018), and poor differentiation (19.6% vs 2.0%, P<.001). Survival analysis showed better survival in the MSI-H group, but the difference was not statistically significant (P=.126). Propensity score matching was performed for significant prognostic factors identified by Cox hazard regression. After the matching, the survival difference by MSI status was estimated to be larger than before, and reached statistical significance (P=.045). In conclusion, after controlling for pathological characteristics, MSI-H could be a potent prognostic factor regarding patient survival. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/MD.0000000000010019 | - |
dc.identifier.scopusid | 2-s2.0-85042745551 | - |
dc.identifier.wosid | 000427995800007 | - |
dc.identifier.bibliographicCitation | Medicine, v.97, no.9 | - |
dc.citation.title | Medicine | - |
dc.citation.volume | 97 | - |
dc.citation.number | 9 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | MISMATCH REPAIR SYSTEM | - |
dc.subject.keywordPlus | LYMPH-NODE RATIO | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | PROGNOSTIC IMPACT | - |
dc.subject.keywordPlus | RECTAL-CANCER | - |
dc.subject.keywordPlus | MSI-H | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | RESECTION | - |
dc.subject.keywordPlus | DISTAL | - |
dc.subject.keywordAuthor | colorectal neoplasms | - |
dc.subject.keywordAuthor | microsatellite instability | - |
dc.subject.keywordAuthor | propensity score | - |
dc.subject.keywordAuthor | survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.